- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
IgA Nephropathy – From Pathogenesis to Current Management
About This Event
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. You will then take a deep dive into the current understanding of IgAN pathogenesis including the four hit cascade and the key role B-cells and APRIL (A PRoliferation-Inducing Ligand) play in driving disease progression.
Location
Venue Restaurant & Lounge
Featuring
Abigail Yancey, PharmD, FCCP, BCPS
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Abigail Yancey, PharmD, FCCP, BCPS, is a Medical Science Liaison at Otsuka Pharmaceuticals Development & Commercialization, Inc. (OPDC). Dr Yancey earned her B.S. in Pharmacy and Doctorate in Pharmacy (PharmD) from St. Louis College of Pharmacy in St. Louis, MO. She completed a pharmacy practice residency at University Hospital in Cincinnati, Ohio and a specialty residency in adult internal medicine at The Ohio State University. Prior to joining Otsuka, she spent 18-years at St. Louis College of Pharmacy as a Professor in the Department of Pharmacy Practice with a clinical practice site at SSM Health St. Mary’s Hospital. Dr Yancey was highly involved as an interdisciplinary educator for internal medicine resident physicians and a preceptor for both pharmacy students and residents. Dr Yancey is a Board Certified Pharmacotherapy Specialist (BCPS) and is a Fellow of the American College of Clinical Pharmacy (FCCP).
Abigail Yancey, PharmD, FCCP, BCPS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
Please Log In Or Join to Register for this Event.
Related Events
-
Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy
January 8, 2025 from 12:00 pm to 1:00 pm
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.